Hribernik, N. (2025) “Early-time-point 18F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy”, Radiology and Oncology, 59(1), pp. 43–53. Available at: https://www.radioloncol.com/index.php/ro/article/view/4548 (Accessed: 12 June 2026).